Radionics / Abrams ERA (Oscilloclast, Dynamizer)

Radionics is where the whole idea begins. In 1910s–20s San Francisco, the physician Albert Abrams built devices — the Dynamizer, the Oscilloclast — that he said could read disease-specific “electronic reactions” from a drop of blood or the body itself, and broadcast corrective frequencies back. This is the Information / Bioresonance family's oldest entry, and its most important one, because nearly everything else in the family is downstream of it. It is also the first such device that was actually put to a blind test — and it failed.

The doctrine

Abrams' “Electronic Reactions of Abrams” (ERA) held that every disease emits a characteristic vibration that a trained operator, using his instruments, could detect and identify — even from a signature or a blood spot on paper — and then neutralise with a broadcast counter-frequency. Strip away the vocabulary and the structure is exactly the one that reappears for the next century: a device reads the body's frequencies and corrects them. That is the template for Rife's “mortal oscillatory rate,” for EAV/Voll electrodermal diagnosis, and for modern bioresonance.

Tested — and not confirmed

ERA did not merely go unstudied. It was investigated, contemporaneously, by serious people. A Scientific American committee ran an investigation across 1923–24 and concluded the claims were unsubstantiated. In a now-famous probe, the American Medical Association sent Abrams a blood sample drawn from a healthy guinea pig, unlabelled, and received back a confident diagnosis of human disease. The Royal Society of Medicine's Horder committee reported on ERA in the BMJ in 1925. Under conditions the operator could not game, the readings carried no information. That is the definition of tested — not confirmed, and it is why this page sits in that tier rather than in the “open, not studied” middle.

Why the tier is “tested,” not “not studied” — a note on the blind spot

An earlier draft of this atlas nearly filed ERA as “not studied, open.” That would have been a mistake — and an instructive one. The investigations that sank ERA were published in 1923–25, in Scientific American and the BMJ, venues and dates that a PubMed-first evidence search does not surface. A device that was tested and failed a century ago can therefore read, to a modern indexed search, as though it were never examined at all. It was examined. The correction is anchored in the contemporaneous record (contemporaneous AMA account; Ernst, Bizarre Medical Ideas, Springer 2024), and the general lesson is logged for the atlas's own method: for any device older than roughly 1950, check the historical literature before assigning a tier.

The origin of a tradition

The reason ERA earns a full entry rather than a footnote is lineage. Abrams is upstream of the entire “instrument reads your frequencies” family. The lineage essay traces the branches; this page marks the root. And the single most telling fact about radionics is not that it failed the 1923–25 tests — it is that the tradition it founded kept going anyway, unchanged in structure, for a hundred years after the result was in. The atlas's oldest entry is also its clearest demonstration that a negative test, by itself, does not stop a doctrine.

Keep vs set aside

Keep: the historical record — ordinary electronics, a clearly stated claim, and an early, honest, blind test of it. As a piece of the map, ERA is essential: it dates and locates the origin of frequency-reading medicine. Set aside: the claim itself. “Electronic reactions” that diagnose disease from a blood spot were tested under blinding and carried no signal; the mechanism contradicts physics. What remains is not a device to use, but a lineage to understand.